Exane Derivatives’s Pathward Financial CASH Stock Holding History
Bought
Maintained
Sold
Other funds holding CASH
NCM
EIP
AAM
Exane Derivatives's CASH Position: Q2 2022 in Review
Exane Derivatives reduced its Pathward Financial (CASH) stake by 10% in Q2 2022, selling an estimated $11.4K and leaving 2,279 shares worth $88.1K. The position accounts for 0.05% of the portfolio, ranked #272.
Exane Derivatives first reported a position in CASH in Q2 2021 and has held it in 5 quarters since. The position peaked at $140K in Q1 2022. 192 funds tracked by Wall St. Rank hold CASH as of Q2 2022.
- Exane Derivatives held 2,279 shares of Pathward Financial worth $88.1K as of Q2 2022.
- Exane Derivatives sold 267 Pathward Financial shares in Q2 2022, an estimated $11.4K.
- Pathward Financial made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #272 holding.
- Exane Derivatives first reported a position in Pathward Financial in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's Pathward Financial position peaked at $140K in Q1 2022.
- 192 funds tracked by Wall St. Rank held Pathward Financial as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.